ÂÜÀòÂÒÂ×

Nicholas Vance is a Senior Scientist at CRELUX, a WuXi AppTec Company, since April 2023, with prior experience as a Scientist II at Carmot Therapeutics, Inc. from May 2022 to April 2023, focusing on structural biology, protein crystallography, and CryoEM. Vance was a Postdoctoral Researcher at Imperial College London from October 2018 to May 2022 and completed a PhD at the University of Iowa from July 2012 to September 2018, where an internship at Genentech in summer 2017 involved work in an antibody-drug conjugate laboratory. Vance holds a Doctor of Pharmacy degree in Medicinal and Natural Products Chemistry from the University of Iowa and a Bachelor of Arts in Biochemistry from Central College.